Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Supreme Court To Hear RICO Complaint Against CBD Firms As Hemp Regulation Remains AWOL

Apr 29 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Chinese Firm Gets Another Chance With RICO Complaint Against California Supplement Provider

Aug 14 2023

US FDA Doubts Hemp ‘Derivatives Created From Scratch’ Belong In Lawful Use Pathway

Feb 06 2023

CBD Market Provides ‘Enormous Incentive’ For FDA's Regulatory Answer But Decision Remains TBD

Dec 10 2020

Hemp Regulation Flags Raised By States Wave Tougher Compliance Cloud Over Industry

Apr 11 2024

First US Warnings On Drug Claims By Delta-8 THC Supplements Also Describe Safety Concerns

May 05 2022

Additional Topics

International United States Dietary Supplements Cannabidiol CBD Litigation Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Consumer FDA Ingredients Manufacturing Legislation Policy Politics Regulation Regulatory

More from Cannabis/CBD

More from Ingredients & Safety

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window